A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis
Public ClinicalTrials.gov record NCT00048932. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to learn if abatacept is safe when co-administered with other approved rheumatoid arthritis medications.
Study identification
- NCT ID
- NCT00048932
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,795 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2002
- Primary completion
- Sep 30, 2009
- Completion
- Sep 30, 2009
- Last update posted
- Nov 23, 2011
2002 – 2009
United States locations
- U.S. sites
- 44
- U.S. states
- 28
- U.S. cities
- 44
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Decatur | Alabama | — | — |
| Local Institution | Paradise | Arizona | — | — |
| Local Institution | Phoenix | Arizona | — | — |
| Local Institution | Tucson | Arizona | — | — |
| Local Institution | San Francisco | California | — | — |
| Local Institution | Loveland | Colorado | — | — |
| Local Institution | Hamden | Connecticut | — | — |
| Local Institution | Lake Worth | Florida | — | — |
| Local Institution | Largo | Florida | — | — |
| Local Institution | Blairsville | Georgia | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Evansville | Indiana | — | — |
| Local Institution | Indianapolis | Indiana | — | — |
| Local Institution | Wichita | Kansas | — | — |
| Local Institution | Louisville | Kentucky | — | — |
| Local Institution | New Orleans | Louisiana | — | — |
| Local Institution | Baltimore | Maryland | — | — |
| Local Institution | Cumberland | Maryland | — | — |
| Local Institution | Westminster | Maryland | — | — |
| Local Institution | Boston | Massachusetts | — | — |
| Local Institution | Grand Rapids | Michigan | — | — |
| Local Institution | Royal Oak | Michigan | — | — |
| Local Institution | Toms River | New Jersey | — | — |
| Local Institution | Los Alamos | New Mexico | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Durham | North Carolina | — | — |
| Local Institution | Hickory | North Carolina | — | — |
| Local Institution | Canton | Ohio | — | — |
| Local Institution | Cleveland | Ohio | — | — |
| Local Institution | Columbus | Ohio | — | — |
| Local Institution | Elyria | Ohio | — | — |
| Local Institution | Youngstown | Ohio | — | — |
| Local Institution | Oklahoma City | Oklahoma | — | — |
| Local Institution | Wyomissing | Pennsylvania | — | — |
| Local Institution | Columbia | South Carolina | — | — |
| Local Institution | Sioux Falls | South Dakota | — | — |
| Local Institution | Ducktown | Tennessee | — | — |
| Local Institution | Nashville | Tennessee | — | — |
| Local Institution | Richmond | Virginia | — | — |
| Local Institution | Edmonds | Washington | — | — |
| Local Institution | Olympia | Washington | — | — |
| Local Institution | Tacoma | Washington | — | — |
| Local Institution | Menomonee Falls | Wisconsin | — | — |
| Local Institution | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00048932, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 23, 2011 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00048932 live on ClinicalTrials.gov.